{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T03:51:03Z","timestamp":1794282663827,"version":"4.9.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T00:00:00Z","timestamp":1668470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T00:00:00Z","timestamp":1668470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Pfizer Inc. (Pfizer Italy) supported this work with an unconditional research grant given to the Tuscan Regional Amyloidosis Centre, Florence, Italy."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1038\/s41431-022-01235-2","type":"journal-article","created":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T08:02:54Z","timestamp":1668499374000},"page":"541-547","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Investigation on the high recurrence of the ATTRv-causing transthyretin variant Val142Ile in central Italy"],"prefix":"10.1038","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6159-9980","authenticated-orcid":false,"given":"Francesco","family":"Mazzarotto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Argir\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Zampieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9933-8666","authenticated-orcid":false,"given":"Chiara","family":"Magri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Giotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Boschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Frusconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Gennarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Buxbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0745-6046","authenticated-orcid":false,"given":"Renato","family":"Polimanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iacopo","family":"Olivotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Perfetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Cappelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,15]]},"reference":[{"key":"1235_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ijcard.2021.04.023","volume":"335","author":"M Zampieri","year":"2021","unstructured":"Zampieri M, Nardi G, del Monaco G, Allinovi M, Gabriele M, Zocchi C, et al. Changes in the perceived epidemiology of amyloidosis: 20 year-experience from a Tertiary Referral Centre in Tuscany. Int J Cardiol. 2021;335:123\u20137. https:\/\/pubmed.ncbi.nlm.nih.gov\/33865873\/.","journal-title":"Int J Cardiol"},{"key":"1235_CR2","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1016\/j.jacc.2019.04.003","volume":"73","author":"FL Ruberg","year":"2019","unstructured":"Ruberg FL, Grogan M, Hanna M, Kelly JW, Maurer MS. Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol. 2019;73:2872\u201391.","journal-title":"J Am Coll Cardiol"},{"key":"1235_CR3","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/mgg3.231","volume":"4","author":"DR Jacobson","year":"2016","unstructured":"Jacobson DR, Alexander AA, Tagoe C, Garvey WT, Williams SM, Tishkoff S, et al. The prevalence and distribution of the amyloidogenic transthyretin (TTR) V122I allele in Africa. Mol Genet Genom Med. 2016;4:548\u201356. https:\/\/pubmed.ncbi.nlm.nih.gov\/27652282\/.","journal-title":"Mol Genet Genom Med"},{"key":"1235_CR4","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/gim.2016.200","volume":"19","author":"JN Buxbaum","year":"2017","unstructured":"Buxbaum JN, Ruberg FL. Transthyretin V122I (pV142I)* cardiac amyloidosis: an age-dependent autosomal dominant cardiomyopathy too common to be overlooked as a cause of significant heart disease in elderly African Americans. Genet Med. 2017;19:733\u201342. https:\/\/pubmed.ncbi.nlm.nih.gov\/28102864\/.","journal-title":"Genet Med"},{"key":"1235_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1056\/NEJMoa1404852","volume":"372","author":"CC Quarta","year":"2015","unstructured":"Quarta CC, Buxbaum JN, Shah AM, Falk RH, Claggett B, Kitzman DW, et al. The amyloidogenic V122I transthyretin variant in elderly black Americans. N Engl J Med. 2015;372:21\u20139. https:\/\/pubmed.ncbi.nlm.nih.gov\/25551524\/.","journal-title":"N Engl J Med"},{"key":"1235_CR6","doi-asserted-by":"publisher","first-page":"122","DOI":"10.2459\/JCM.0000000000000290","volume":"17","author":"F Cappelli","year":"2016","unstructured":"Cappelli F, Frusconi S, Bergesio F, Grifoni E, Fabbri A, Giuliani C, et al. The Val142Ile transthyretin cardiac amyloidosis: not only an Afro-American pathogenic variant? A single-centre Italian experience. J Cardiovasc Med. 2016;17:122\u20135. https:\/\/pubmed.ncbi.nlm.nih.gov\/26428663\/.","journal-title":"J Cardiovasc Med"},{"key":"1235_CR7","doi-asserted-by":"publisher","first-page":"26931","DOI":"10.3402\/jchimp.v5.26931","volume":"5","author":"F Perfetto","year":"2015","unstructured":"Perfetto F, Frusconi S, Bergesio F, Grifoni E, Fabbri A, Giuliani C, et al. The Val142Ile transthyretin cardiac amyloidosis: more than an Afro-American pathogenic variant. J Community Hosp Intern Med Perspect. 2015;5:26931 https:\/\/pubmed.ncbi.nlm.nih.gov\/25846356\/.","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"1235_CR8","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/jns.12385","volume":"25","author":"L Gentile","year":"2020","unstructured":"Gentile L, di Bella G, Minutoli F, Cucinotta F, Obici L, Mussinelli R, et al. Description of a large cohort of Caucasian patients with V122I ATTRv amyloidosis: Neurological and cardiological features. J Peripheral Nerv Syst. 2020;25:273\u20138. https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1111\/jns.12385.","journal-title":"J Peripheral Nerv Syst"},{"key":"1235_CR9","doi-asserted-by":"publisher","first-page":"e003466","DOI":"10.1161\/CIRCGEN.121.003466","volume":"14","author":"BH Trachtenberg","year":"2021","unstructured":"Trachtenberg BH, Shah SK, Nussbaum RL, Bristow SL, Malladi R, Vatta M. Presence of the V122I variant of hereditary transthyretin-mediated amyloidosis among self-reported white individuals in a sponsored genetic testing program. Circ Genom Precis Med. 2021;14:e003466 https:\/\/www.ahajournals.org\/doi\/abs\/10.1161\/CIRCGEN.121.003466.","journal-title":"Circ Genom Precis Med"},{"key":"1235_CR10","unstructured":"\u00c1lvarez Rubio J, Manovel S\u00e1nchez AJ, Gonz\u00e1lez-Costello J, Garc\u00eda-Pav\u00eda P, Limeres Freire J, Garc\u00eda-Pinilla JM, et al. Characterization of hereditary transthyretin cardiac amyloidosis in Spain. Rev Esp Cardiol (English Ed). 2021. http:\/\/www.revespcardiol.org\/en-characterization-hereditary-transthyretin-cardiac-amyloidosis-avance-S1885585721002929."},{"key":"1235_CR11","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3109\/13506129.2015.1051219","volume":"22","author":"DR Jacobson","year":"2015","unstructured":"Jacobson DR, Alexander AA, Tagoe C, Buxbaum JN. Prevalence of the amyloidogenic transthyretin (TTR) V122I allele in 14 333 African-Americans. Amyloid. 2015;22:171\u20134. https:\/\/pubmed.ncbi.nlm.nih.gov\/26123279\/.","journal-title":"Amyloid"},{"key":"1235_CR12","doi-asserted-by":"publisher","first-page":"e003356","DOI":"10.1161\/CIRCGEN.121.003356","volume":"14","author":"P Chandrashekar","year":"2021","unstructured":"Chandrashekar P, Alhuneafat L, Mannello M, Al-Rashdan L, Kim MM, Dungu J, et al. Prevalence and outcomes of p.Val142Ile TTR amyloidosis cardiomyopathy: a systematic review. Circ Genom Precis Med. 2021;14:e003356 https:\/\/pubmed.ncbi.nlm.nih.gov\/34461737\/.","journal-title":"Circ Genom Precis Med"},{"key":"1235_CR13","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/BF00278187","volume":"78","author":"DN Cooper","year":"1988","unstructured":"Cooper DN, Youssoufian H. The CpG dinucleotide and human genetic disease. Hum Genet. 1988;78:151\u20135. https:\/\/pubmed.ncbi.nlm.nih.gov\/3338800\/.","journal-title":"Hum Genet"},{"key":"1235_CR14","doi-asserted-by":"crossref","unstructured":"Lahrouchi N, Postma A v., Salazar CM, de Laughter DM, Tjong F, Piherov\u00e1 L, et al. Biallelic loss-of-function variants in PLD1 cause congenital right-sided cardiac valve defects and neonatal cardiomyopathy. J Clin Investig 2021;131:\/pmc\/articles\/PMC7919725\/","DOI":"10.1172\/JCI142148"},{"key":"1235_CR15","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s12471-013-0401-3","volume":"21","author":"PA van der Zwaag","year":"2013","unstructured":"van der Zwaag PA, van Rijsingen IAW, de Ruiter R, Nannenberg EA, Groeneweg JA, Post JG, et al. Recurrent and founder mutations in the Netherlands-Phospholamban p.Arg14del mutation causes arrhythmogenic cardiomyopathy. Neth Heart J. 2013;21:286\u201393. https:\/\/pubmed.ncbi.nlm.nih.gov\/23568436\/.","journal-title":"Neth Heart J"},{"key":"1235_CR16","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.ehj.2004.01.020","volume":"25","author":"S K\u00e4rkk\u00e4inen","year":"2004","unstructured":"K\u00e4rkk\u00e4inen S, Heli\u00f6 T, Miettinen R, Tuomainen P, Peltola P, Rummukainen J, et al. A novel mutation, Ser143Pro, in the lamin A\/C gene is common in finnish patients with familial dilated cardiomyopathy. Eur Heart J. 2004;25:885\u201393. https:\/\/pubmed.ncbi.nlm.nih.gov\/15140538\/.","journal-title":"Eur Heart J"},{"key":"1235_CR17","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1161\/CIRCGEN.120.002991","volume":"13","author":"AC Fahed","year":"2020","unstructured":"Fahed AC, Nemer G, Bitar FF, Arnaout S, Abchee AB, Batrawi M, et al. Founder mutation in N terminus of cardiac Troponin I causes malignant hypertrophic cardiomyopathy. Circ Genom Precis Med [Internet]. 2020;13:444\u201352. https:\/\/pubmed.ncbi.nlm.nih.gov\/32885985\/.","journal-title":"Circ Genom Precis Med [Internet]"},{"key":"1235_CR18","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1080\/13506129.2019.1634539","volume":"26","author":"A Kirov","year":"2019","unstructured":"Kirov A, Sarafov S, Pavlova Z, Todorov T, Chamova T, Gospodinova M, et al. Founder effect of the Glu89Gln TTR mutation in the Bulgarian population. Amyloid. 2019;26:181\u20135. https:\/\/pubmed.ncbi.nlm.nih.gov\/31353960\/.","journal-title":"Amyloid"},{"key":"1235_CR19","doi-asserted-by":"crossref","unstructured":"Arauna LR, Hellenthal G, Comas D. Dissecting human North African gene-flow into its western coastal surroundings. Proc R. Soc B. 2019. https:\/\/royalsocietypublishing.org\/doi\/abs\/10.1098\/rspb.2019.0471","DOI":"10.1098\/rspb.2019.0471"},{"key":"1235_CR20","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/ejhg.2015.233","volume":"24","author":"G Fiorito","year":"2016","unstructured":"Fiorito G, di Gaetano C, Guarrera S, Rosa F, Feldman MW, Piazza A, et al. The Italian genome reflects the history of Europe and the Mediterranean basin. Eur J Hum Genet. 2016;24:1056\u201362. https:\/\/www.nature.com\/articles\/ejhg2015233.","journal-title":"Eur J Hum Genet"},{"key":"1235_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.fsigen.2014.02.012","volume":"11","author":"C Phillips","year":"2014","unstructured":"Phillips C, Parson W, Lundsberg B, Santos C, Freire-Aradas A, Torres M, et al. Building a forensic ancestry panel from the ground up: the EUROFORGEN Global AIM-SNP set. Forensic Sci Int Genet. 2014;11:13\u201325.","journal-title":"Forensic Sci Int Genet"},{"key":"1235_CR22","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","volume":"42","author":"P Garcia-Pavia","year":"2021","unstructured":"Garcia-Pavia P, Rapezzi C, Adler Y, Arad M, Basso C, Brucato A, et al. Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2021;42:1554.","journal-title":"Eur Heart J"},{"key":"1235_CR23","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","volume":"133","author":"JD Gillmore","year":"2016","unstructured":"Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A, et al. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation. 2016;133:2404\u201312. https:\/\/pubmed.ncbi.nlm.nih.gov\/27143678\/.","journal-title":"Circulation"},{"key":"1235_CR24","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","volume":"21","author":"JC Barrett","year":"2005","unstructured":"Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263\u20135. https:\/\/academic.oup.com\/bioinformatics\/article\/21\/2\/263\/186662.","journal-title":"Bioinformatics"},{"key":"1235_CR25","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1038\/ng.3679","volume":"48","author":"PR Loh","year":"2016","unstructured":"Loh PR, Danecek P, Palamara PF, Fuchsberger C, Reshef YA, Finucane HK, et al. Reference-based phasing using the Haplotype Reference Consortium panel. Nat Genet. 2016;48:1443\u20138. https:\/\/www.nature.com\/articles\/ng.3679.","journal-title":"Nat Genet"},{"key":"1235_CR26","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1126\/science.1069424","volume":"296","author":"SB Gabriel","year":"2002","unstructured":"Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, et al. The structure of haplotype blocks in the human genome. Science. 2002;296:2225\u20139. https:\/\/www.science.org\/doi\/full\/10.1126\/science.1069424.","journal-title":"Science"},{"key":"1235_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/oxfordjournals.molbev.a026036","volume":"16","author":"HJ Bandelt","year":"1999","unstructured":"Bandelt HJ, Forster P, R\u00f6hl A. Median-joining networks for inferring intraspecific phylogenies. Mol Biol Evol. 1999;16:37\u201348. https:\/\/pubmed.ncbi.nlm.nih.gov\/10331250\/.","journal-title":"Mol Biol Evol"},{"key":"1235_CR28","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/humu.23348","volume":"39","author":"PJ Freeman","year":"2018","unstructured":"Freeman PJ, Hart RK, Gretton LJ, Brookes AJ, Dalgleish R. VariantValidator: accurate validation, mapping, and formatting of sequence variation descriptions. Hum Mutat. 2018;39:61\u20138. https:\/\/pubmed.ncbi.nlm.nih.gov\/28967166\/.","journal-title":"Hum Mutat"},{"key":"1235_CR29","doi-asserted-by":"publisher","unstructured":"Arruda-Olson AM, Zeldenrust SR, Dispenzieri A, Gertz MA, Miller FA, Bielinski SJ, et al. Genotype, echocardiography, and survival in familial transthyretin amyloidosis. 2013. https:\/\/doi.org\/10.3109\/135061292013845745.","DOI":"10.3109\/135061292013845745"},{"key":"1235_CR30","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/eurheartj\/ehz173","volume":"43","author":"T Damy","year":"2022","unstructured":"Damy T, Kristen AV, Suhr OB, Maurer MS, Plant\u00e9-Bordeneuve V, Yu CR, et al. Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS). Eur Heart J. 2022;43:391\u2013400. https:\/\/academic.oup.com\/eurheartj\/article\/43\/5\/391\/5425268.","journal-title":"Eur Heart J"},{"key":"1235_CR31","doi-asserted-by":"crossref","unstructured":"Batra J, Rosenblum H, Cappelli F, Zampieri M, Olivotto I, Griffin JM, et al. Racial differences in Val122Ile-associated transthyretin cardiac amyloidosis. J Card Fail. 2021;28:950\u20139.","DOI":"10.1016\/j.cardfail.2021.12.016"},{"key":"1235_CR32","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/j.1469-1809.2008.00439.x","volume":"72","author":"C Zaros","year":"2008","unstructured":"Zaros C, Genin E, Hellman U, Saporta MA, Languille L, Wadington-cruz M, et al. On the origin of the transthyretin Val30Met familial amyloid polyneuropathy. Ann Hum Genet. 2008;72:478\u201384. https:\/\/pubmed.ncbi.nlm.nih.gov\/18460047\/.","journal-title":"Ann Hum Genet"},{"key":"1235_CR33","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1093\/eurheartj\/ehv583","volume":"37","author":"T Damy","year":"2016","unstructured":"Damy T, Costes B, Hag\u00e8ge AA, Donal E, Eicher JC, Slama M, et al. Prevalence and clinical phenotype of hereditary transthyretin amyloid cardiomyopathy in patients with increased left ventricular wall thickness. Eur Heart J. 2016;37:1826\u201334. https:\/\/pubmed.ncbi.nlm.nih.gov\/26537620\/.","journal-title":"Eur Heart J"},{"key":"1235_CR34","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1093\/eurheartj\/ehz298","volume":"40","author":"M Emdin","year":"2019","unstructured":"Emdin M, Aimo A, Rapezzi C, Fontana M, Perfetto F, Seferovi\u0107 PM, et al. Treatment of cardiac transthyretin amyloidosis: an update. Eur Heart J. 2019;40:3699\u2013706. https:\/\/pubmed.ncbi.nlm.nih.gov\/31111153\/.","journal-title":"Eur Heart J"},{"key":"1235_CR35","doi-asserted-by":"publisher","first-page":"E008193","DOI":"10.1161\/CIRCHEARTFAILURE.120.008193","volume":"15","author":"P Elliott","year":"2022","unstructured":"Elliott P, Drachman BM, Gottlieb SS, Hoffman JE, Hummel SL, Lenihan DJ, et al. Long-term survival with tafamidis in patients with transthyretin amyloid cardiomyopathy. Circ Heart Fail. 2022;15:E008193 https:\/\/www.ahajournals.org\/doi\/abs\/10.1161\/CIRCHEARTFAILURE.120.008193.","journal-title":"Circ Heart Fail"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-022-01235-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-022-01235-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-022-01235-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T23:07:37Z","timestamp":1683760057000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-022-01235-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,15]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["1235"],"URL":"https:\/\/doi.org\/10.1038\/s41431-022-01235-2","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,15]]},"assertion":[{"value":"18 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All participants gave written informed consent and the study was approved by the local ethics committee (reference number: CEAVC 16021).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}